Back to Trades
Total Value
$438.0K
Filing Date
Mar 24, 2026
1 transactions
Trade Summary
On Mar 20, 2026, BRIGHAM MICHAEL F, Director, reported $438.0K of IMMUCELL CORP /DE/ (ICCC) across 1 transactions. The filing covers Common Stock, par value $.01 per share and reflects balanced net activity of $0. Reported prices ranged from $5.84 to $6.07. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- IMMUCELL CORP /DE/
- Ticker Symbol
- ICCC
- CIK
- 0000811641
Insider Information
- Role
- Director
- Location
- PORTLAND, ME
Filing Details
- Filing Date
- Mar 24, 2026
- Transaction Date
- Mar 20, 2026
- Accession Number
- 0001437749-26-009661
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Mar 20, 2026 | Common Stock, par value $.01 per share | 25,000 | $5.84 | Exercise | $146.0K |
| Mar 20, 2026 | Common Stock, par value $.01 per share | 24,052 | $6.07 | Tax Withholding | $146.0K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Mar 20, 2026 | ICCC derivative | 25,000 | $5.84 | Exercise | $146.0K |
Want live alerts when BRIGHAM MICHAEL F trades again?
Download Insider Trades to track ICCC, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Number of shares resulting from stock-for-stock exercise of stock option. The Reporting Person surrendered previously owned shares in full payment of the exercise price for that option.
- (F2)Number of shares surrendered to the Issuer in payment of the exercise price of the option.